FlexISH ® BCL2/BCL6 DistinguISHTM Probe

The FlexISH ® BCL2/BCL6 DistinguISHTM Probe is designed to detect rearrangements involving the chromosomal regions 18q21.33 and 3q27.3 harboring the BCL2 (B-Cell CLL/Lymphoma 2, a.k.a. PPP1R50) gene and the BCL6 (B-Cell CLL/ Lymphoma 6, a.k.a. ZNF51, LAZ3) gene, respectively. Using this probe, it is possible to simultaneously detect BCL2 and/or BCL6 rearrangements commonly found in double-hit lymphoma (DHL) or triple-hit lymphoma (THL).

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
5 (50 µl)
20 (200 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue